Androgen deprivation therapy may reduce the risk of primary open-angle glaucoma in patients with prostate cancer: a nationwide population-based cohort study
Open Access
- 29 May 2021
- journal article
- research article
- Published by Elsevier in Prostate International
- Vol. 9 (4) , 197-202
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040Ophthalmology, 2014
- The Pathophysiology and Treatment of GlaucomaJAMA, 2014
- The Potential Association Between Postmenopausal Hormone Use and Primary Open-Angle GlaucomaJAMA Ophthalmology, 2014
- Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trialThe Lancet, 2011
- Open-Angle Glaucoma—An Epidemiologic OverviewOphthalmic Epidemiology, 2007
- Variations in Primary Open-Angle Glaucoma Prevalence by Age, Gender, and Race: A Bayesian Meta-AnalysisInvestigative Ophthalmology & Visual Science, 2006
- The number of people with glaucoma worldwide in 2010 and 2020British Journal of Ophthalmology, 2006
- Influence of Serum Levels of Sex Hormones on Intraocular Pressure in Menopausal WomenJournal of Glaucoma, 2003
- Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressuresAmerican Journal of Ophthalmology, 1998
- GENETIC INFLUENCES IN OPEN-ANGLE GLAUCOMAInternational Ophthalmology Clinics, 1990